» Memory Pharmaceuticals Presents Positive Preclinical Data For MEM 68626 At ICAD 2008
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) presented preclinical data for MEM 68626, its lead 5-HT6 antagonist drug candidate, at the 2008 Alzheimer’s Association International Conference on…